MRVL.V - Marvel Biosciences Corp.

TSXV - TSXV Real Time Price. Currency in CAD
Currency in CAD

Valuation Measures4

Market Cap (intraday) 3.58M
Enterprise Value 3.28M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)240.16
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.20

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-5.00%
S&P500 52-Week Change 32.74%
52 Week High 30.1700
52 Week Low 30.0750
50-Day Moving Average 30.0950
200-Day Moving Average 30.1078

Share Statistics

Avg Vol (3 month) 316.89k
Avg Vol (10 day) 322.74k
Shares Outstanding 539.79M
Implied Shares Outstanding 6N/A
Float 832.66M
% Held by Insiders 132.47%
% Held by Institutions 10.00%
Shares Short (May 14, 2023) 47k
Short Ratio (May 14, 2023) 40.45
Short % of Float (May 14, 2023) 4N/A
Short % of Shares Outstanding (May 14, 2023) 40.02%
Shares Short (prior month Feb 14, 2023) 4229

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2022
Most Recent Quarter (mrq)Jan 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-116.44%
Return on Equity (ttm)-380.30%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.45M
Net Income Avi to Common (ttm)-1.5M
Diluted EPS (ttm)-0.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)298.33k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.02
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-1.25M
Levered Free Cash Flow (ttm)-655.57k